ACADIA Pharmaceuticals Inc.
ACAD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $258 | $254 | $218 | $320 |
| Short-Term Investments | $589 | $508 | $464 | $436 |
| Receivables | $139 | $120 | $114 | $105 |
| Inventory | $29 | $26 | $23 | $22 |
| Other Curr. Assets | $61 | $53 | $53 | $56 |
| Total Curr. Assets | $1,076 | $961 | $871 | $938 |
| Property Plant & Equip (Net) | $53 | $55 | $54 | $51 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $112 | $114 | $117 | $120 |
| Long-Term Investments | $9 | $9 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $80 | $87 | $90 | $79 |
| Total NC Assets | $254 | $265 | $261 | $249 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,331 | $1,226 | $1,132 | $1,188 |
| Liabilities | – | – | – | – |
| Payables | $22 | $20 | $18 | $16 |
| Short-Term Debt | $12 | $12 | $11 | $10 |
| Tax Payable | $0 | $0 | $9 | $12 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $323 | $298 | $264 | $357 |
| Total Curr. Liab. | $357 | $330 | $303 | $395 |
| LT Debt | $43 | $45 | $45 | $42 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $14 | $29 | $20 | $18 |
| Total NC Liab. | $57 | $73 | $65 | $60 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $43 | $45 | $56 | $52 |
| Total Liabilities | $413 | $403 | $367 | $455 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$2,087 | -$2,159 | -$2,185 | -$2,204 |
| AOCI | $1 | $0 | $0 | $0 |
| Other Equity | $3,003 | $2,981 | $2,950 | $2,937 |
| Total Equity | $917 | $822 | $765 | $733 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,331 | $1,226 | $1,132 | $1,188 |
| Net Debt | -$203 | -$197 | -$162 | -$268 |